Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges
Shimin Xie, Zhengguo Wu, Yi Qi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111450-111450
Open Access | Times Cited: 114

Showing 26-50 of 114 citing articles:

A review of obstructive sleep apnea and lung cancer: epidemiology, pathogenesis, and therapeutic options
Yuan Fang, Yanxia Hu, Fei Xu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Non-Coding RNA as a Biomarker in Lung Cancer
C. Raman Suri, Shashikant Swarnkar, L.V.K.S. Bhaskar, et al.
Non-Coding RNA (2024) Vol. 10, Iss. 5, pp. 50-50
Open Access | Times Cited: 4
Theoretical perspectives and clinical applications of non-coding RNA in lung cancer metastasis: a systematic review
Jie Yang, Yixin Luo, Zuhuan Yao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Metallothionein 2A enhances the yes-associated protein 1 signaling pathway to promote small-cell lung cancer metastasis
Hong Wu, Yangyang Gu, Lidong Xu
CytoJournal (2025) Vol. 22, pp. 25-25
Open Access
HNRNPC promotes progression of non-small cell lung cancer by maintaining TFAP2A mRNA stability
Minghua Liao, Chunyu Li, Rui Yang, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Recent Advancements in Lung Cancer Metastasis Prevention Based on Nanostrategies
Fan Xu, Yao Liu, Zujun Que, et al.
Advanced Science (2025)
Open Access
Probing the biological activity of isatin derivatives against human lung cancer A549 cells: Cytotoxicity, CT-DNA/BSA binding, DFT/TD-DFT, topology, ADME-Tox, docking and dynamic simulations
Mehran Feizi‐Dehnayebi, Ghodsi Mohammadi Ziarani, T.N. Lohith, et al.
Journal of Molecular Liquids (2025), pp. 127475-127475
Closed Access
R predicting lung cancer bone metastasis using CT and pathological imaging with a Swin Transformer model
Wanling Li, Xinhua Zou, Jie Zhang, et al.
Journal of bone oncology (2025), pp. 100681-100681
Open Access
Mesenchymal stem cells: ideal seeds for treating diseases
Guanwen Gao, Chenyang Fan, James Weiquan Li, et al.
Human Cell (2021) Vol. 34, Iss. 6, pp. 1585-1600
Open Access | Times Cited: 23
The anti-lung cancer activity of propylene tethered dihydroartemisinin-isatin hybrids
Zhe Zhang, Dong Zhang, Yanhui Zhou, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 4, pp. 103721-103721
Open Access | Times Cited: 16
Exploration of kiwi root on non-small cell lung cancer based on network pharmacology and molecular docking
Ruochen Li, Mingxiao Wang, Jin Tian, et al.
Medicine (2024) Vol. 103, Iss. 1, pp. e36852-e36852
Open Access | Times Cited: 3
circNINL facilitates aerobic glycolysis, proliferation, invasion, and migration in lung cancer by sponging miR-3918 to mediate FGFR1 expression
Sai Li, Chun Qiu, DaTong Sun, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 3
Moving beyond traditional therapies: the role of nanomedicines in lung cancer
Jingjing Zhang, Yanzhi Li, Sa Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Epithelial–mesenchymal transition to Mitigate Age-Related Progression in Lung Cancer
Riya Thapa, Saurabh Gupta, Gaurav Gupta, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102576-102576
Closed Access | Times Cited: 3
Extracellular RNA as a kind of communication molecule and emerging cancer biomarker
Danny Wu, Tao Tao, Emily Eshraghian, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
Tailoring biomaterials for monitoring and evoking tertiary lymphoid structures
Hao Li, Wen‐Ping Lin, Zhong-Ni Zhang, et al.
Acta Biomaterialia (2023) Vol. 172, pp. 1-15
Open Access | Times Cited: 8
Phytosphingosine inhibits the growth of lung adenocarcinoma cells by inducing G2/M-phase arrest, apoptosis, and mitochondria-dependent pathway cell death in vitro and in vivo
Qi Cai, Min Chen, Bo Wang, et al.
Chemico-Biological Interactions (2023) Vol. 387, pp. 110795-110795
Open Access | Times Cited: 8
Identified Gefitinib Metabolism-Related lncRNAs can be Applied to Predict Prognosis, Tumor Microenvironment, and Drug Sensitivity in Non-Small Cell Lung Cancer
Weilong Ye, Zhengguo Wu, Pengbo Gao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Ubiquitylation of RUNX3 by RNA-binding ubiquitin ligase MEX3C promotes tumorigenesis in lung adenocarcinoma
Zelai He, Huijun Zhang, Haibo Xiao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Shrimp Lipids Inhibit Migration, Epithelial–Mesenchymal Transition, and Cancer Stem Cells via Akt/mTOR/c-Myc Pathway Suppression
Chorpaka Thepthanee, Zin Zin, Soottawat Benjakul, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 722-722
Open Access | Times Cited: 2
Cancer cell-derived exosome based dual-targeted drug delivery system for non-small cell lung cancer therapy
Jun Wang, Xinyi Zhu, Huijun Jiang, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 244, pp. 114141-114141
Closed Access | Times Cited: 2
Gastric and colonic metastasis from NSCLC
Martina Catalano, Andrea Marini, Katia Ferrari, et al.
Medicine (2022) Vol. 101, Iss. 2, pp. e28249-e28249
Open Access | Times Cited: 12
Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma
Yue Xu, Tao Tao, Yong Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 11
Circ_0000520 interacts with miR-512-5p to upregulate KIAA0100 to promote malignant behaviors in lung cancer.
Linxuan Wang, Wenjing Jin, Xiaochi Wu, et al.
PubMed (2023) Vol. 38, Iss. 1, pp. 73-89
Closed Access | Times Cited: 6
Comprehensive assessment of base excision repair (BER)-related lncRNAs as prognostic and functional biomarkers in lung adenocarcinoma: implications for personalized therapeutics and immunomodulation
Junzheng Zhang, Lu Song, Guanrong Li, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 19, pp. 17199-17213
Closed Access | Times Cited: 6

Scroll to top